Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

SELL
$35.77 - $58.38 $74,973 - $122,364
-2,096 Reduced 31.18%
4,627 $265,000
Q1 2023

May 05, 2023

SELL
$27.99 - $37.92 $79,267 - $107,389
-2,832 Reduced 29.64%
6,723 $252,000
Q4 2022

Feb 03, 2023

BUY
$27.93 - $31.27 $266,871 - $298,784
9,555 New
9,555 $267,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.64B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Watershed Asset Management, L.L.C. Portfolio

Follow Watershed Asset Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watershed Asset Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Watershed Asset Management, L.L.C. with notifications on news.